Feb 14, 2024 · Compare risks and benefits of common medications used for Plaque Psoriasis. Find the most popular drugs, view ratings and user reviews.

Dec 28, 2024 · Other new systemic treatments for plaque psoriasis are the interleukin-23 antagonists risankizumab (Skyrizi), tildrakizumab (Ilumya), and guselkumab (Tremfya). …

Jan 14, 2024 · Compare risks and benefits of common medications used for Psoriasis. Find the most popular drugs, view ratings and user reviews.

May 28, 2025 · The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for the treatment of plaque psoriasis of the scalp and body in

Jul 29, 2025 · Plaque Psoriasis Skyrizi, Tremfya, and Ilumya are approved for treating moderate to severe plaque psoriasis. Clinical trials have shown impressive results, with around 75% of …

Johnson & Johnson Seeks First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis

Jul 7, 2025 · A dermatologist can diagnose psoriasis and help develop a treatment plan tailored to your needs. Psoriasis is a lifelong condition, but with the right care, most people can manage …

Oct 30, 2024 · Imuldosa (ustekinumab-srlf) is a biosimilar to Stelara that may be used to treat Crohn's disease, ulcerative colitis, moderate to severe plaque psoriasis, and active psoriatic …

Jun 24, 2025 · Steqeyma is an interchangeable biosimilar to Stelara used to treat Crohn's disease, ulcerative colitis, moderate to severe plaque psoriasis, and active psoriatic arthritis.

6 days ago · How is psoriasis treated? Treatment depends on how severe your symptoms are, the size of the areas involved, and the type of psoriasis. You may need any of the following: …